Sat.Jun 17, 2023 - Fri.Jun 23, 2023

article thumbnail

Reducing Readmission Rates for Hospitals: 5 Essential Strategies

cureatr

In 2018 (the most recent year for data), the Agency for Healthcare Research and Quality (AHRQ) reported a total of 3.8 million adult hospital readmissions within 30 days, with an average readmission rate of 14% and an average readmission cost to hospitals of $15,200.

article thumbnail

AI has secured a footing in drug discovery. Where does it go from here?

PharmaVoice

The AI revolution is bringing a new era of drug discovery, and the potential for more uses is greater and faster than ever before.

270
270
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The spotlight is on accelerated approvals — now FDA could run a tighter ship

PharmaVoice

As the fallout of the Aduhelm approval continues, scrutiny of the speedier pathway has increased and the pressure is on to close a key gap in the regulation.

189
189
article thumbnail

Can forecasting help identify market opportunities for pharmaceutical companies?

pharmaphorum

Can forecasting help identify market opportunities for pharmaceutical companies? Mike.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

First adult anti-inflammatory cardiovascular drug approved

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved LODOCO ® , the “first drug to target cardiovascular inflammation,” reported Dr Paul Ridker, MPH, Professor of medicine at Harvard Medical School and Director of the Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital. It is the first anti-inflammatory cardiovascular treatment demonstrated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adults with establ

article thumbnail

Flagship’s latest startup aims to take the guesswork out of small molecule drugs

BioPharma Dive

Empress Therapeutics claims its technology allows it to identify chemical drug candidates faster and more reliably. It has $50 million from Flagship to prove it can.

117
117

More Trending

article thumbnail

WHO grants emergency use listing to SK bioscience’s SKYCovione

Pharmaceutical Technology

The World Health Organisation (WHO) has granted an emergency use listing (EUL) to SK bioscience’s Covid-19 vaccine, SKYCovione. SKYCovione is a self-assembled nanoparticle vaccine and the 12th Covid-19 vaccine to receive a EUL from the regulator. Developed using pharmaceutical company GSK’s pandemic adjuvant, the vaccine targets the receptor-binding domain of the SARS-CoV-2 spike protein.

Vaccines 145
article thumbnail

Alchemab Therapeutics reveals Alzheimer’s candidate

Pharma Times

ATLX-1088 is regarded as a possible first-in-class human antibody targeting CD33 – a cell surface protein - News - PharmaTimes

130
130
article thumbnail

Pharmacy pressures impacting medicine supply to NHS community teams

The Pharmacist

Pressures within community pharmacy and subsequent closures are having a negative knock-on effect on some NHS community services, The Pharmacist has been told. One trust in the West of England has reported that such pressures have indirectly impacted its supply of medicines to community hospitals, clinics, nursing teams and a prison. Susan Watkins, chief pharmacist […] The post Pharmacy pressures impacting medicine supply to NHS community teams appeared first on The Pharmacist.

article thumbnail

Could novel robotic oral pill replace traditional injections?

European Pharmaceutical Review

A novel oral ‘robotic pill’ demonstrated a high success rate of drug delivery , according to clinical trial data presented at the Endocrine Society ’s annual meeting (ENDO 2023). “We believe this study provides the first clinical evidence of safe and successful delivery of the osteoporosis drug teriparatide through an oral robotic pill,” stated Arvinder Dhalla, Vice President of Clinical Development at Rani Therapeutics, which was the company that developed the technology.

98
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Current Dementia Risk Assessment Models Limited in Ability to Predict Disease

Pharmacy Times

Standard prediction models that assess an individual’s risk of developing dementia and how to prevent it are limited in their ability to do so, showing high error rates and a higher chance of receiving a false-positive result, according to a recent study.

55
article thumbnail

STAT+: Two type 1 diabetes patients now freed from insulin shots with cell therapy, Vertex reports

STAT

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.  The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients.

Diabetes 364
article thumbnail

10 years proud: Pharma’s top companies for LGBTQ+ inclusivity

PharmaVoice

These six Big Pharma companies have ranked among the best places to work for LGTBQ+ equality by the Human Rights Campaign Foundation for over 10 years. Here’s why.

246
246
article thumbnail

Nanopharmaceutics and PrecisionLife in research collaboration

Pharma Times

Companies’ precision medicine approach has potential to increase clinical trial success rates - News - PharmaTimes

135
135
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Generative Health: A new standard of care

pharmaphorum

Generative Health: A new standard of care Mike.

130
130
article thumbnail

Xylazine, or ‘tranq,’ is making opioid overdoses harder to reverse

STAT

For years, public health guidance about opioid overdoses has been relatively simple: Administer naloxone , then call 911. But the days of simply spraying naloxone into an overdose victim’s nose, then watching that person resume breathing and wake up within minutes, are over.

349
349
article thumbnail

How Sanofi is taking a ‘creative’ approach to dealmaking

PharmaVoice

Dr. Monika Vnuk, SVP of global partnering and business development, is setting her sights on out-of-the-box partnerships.

130
130
article thumbnail

Blood Cancer UK extends collaboration with RareCan

Pharma Times

The organisations will focus on the delivery of clinical trials which concentrate on rare cancers - News - PharmaTimes

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

UniQure stock tumbles on ‘confusing’ results for Huntington’s gene therapy

BioPharma Dive

While treated patients appear to be doing better than history suggests they would, mixed findings involving a key surrogate marker perplexed Wall Street analysts and sent shares falling 38%.

122
122
article thumbnail

STAT+: After promising early data, gene therapy trial for Huntington’s takes puzzling turn

STAT

Last year, after a string of high-profile trial failures , the Huntington’s disease community got positive news in the form of very early data from an experimental gene therapy for the rare neurodegenerative condition. On Wednesday, however, the company behind the drug released updated figures that were more mixed — even befuddling. The study from Uniqure, a Dutch biotech, randomized early stage Huntington’s patients to receive low-dose treatment, a high-dose treatment, or a

article thumbnail

DIA’s chief exec is on a mission to grow its footprint across healthcare

PharmaVoice

Marwan Fathallah came onboard earlier this year to lead the organization into an era of change.

130
130
article thumbnail

FluoGuide announces head and neck cancer therapy results

Pharma Times

The treatment is administered intravenously prior to surgery, lighting up cancer during surgery - News - PharmaTimes

130
130
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Swiss hospital adopts Bayer’s AI platform for radiology

pharmaphorum

Swiss hospital adopts Bayer’s AI platform for radiology Phil.

Hospitals 122
article thumbnail

Opinion: The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope

STAT

When I was diagnosed with Duchenne muscular dystrophy 20 years ago, there was no hope. The guidance the diagnosing doctor gave my parents was simple: Love your child as much as you can now because he won’t be here very long. That was the inspiration that my mom needed to start CureDuchenne. Her intention — our whole family’s intention — was to cure this disease so no other parents would have to go through the same traumatic prognosis.

340
340
article thumbnail

Duty to serve: an Army officer’s unexpected path to GSK

PharmaVoice

How Court Horncastle, SVP, business unit head of the anti-infective and respiratory team at GSK, applies lessons from combat to his work in antibiotics.

130
130
article thumbnail

Poolbeg progress oral vaccine programme

Pharma Times

Poolbeg’s platform will possess the capability to generate vaccines for a wide range of diseases - News - PharmaTimes

Vaccines 130
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

The World Without Disease: Live Coverage

pharmaphorum

The World Without Disease: Live Coverage Mike.

121
121
article thumbnail

STAT+: GSK settles first lawsuit set for a U.S. trial over cancer links to Zantac

STAT

GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such case that was about to go to trial in the U.S. In a brief statement , the company disclosed that it reached a settlement with James Goetz, who filed a lawsuit in a California state court. The deal reflected its desire “to avoid distraction related to protracted litigation in this case.

328
328
article thumbnail

Woman of the Week: Stealth BioTherapeutics’ Reenie McCarthy

PharmaVoice

How the CEO navigated a regulatory odyssey to bring the company’s lead program for an ultra-rare disease to a fast track approval.

130
130
article thumbnail

Greener NHS and NHS Innovation Accelerator collaborate

Pharma Times

Partnership will help NHS to prepare for fundamental change, including reducing carbon emissions - News - PharmaTimes

130
130
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.